Search Orphan Drug Designations and Approvals
-
Generic Name: | heterodimeric fusion protein that binds to IL-1 beta consisting of human extracellular domain of IL1 receptor and a mutant Fc fragment of human IgG1 and part of human IL1 receptor accessory protein |
---|---|
Date Designated: | 10/15/2018 |
Orphan Designation: | Treatment of Schnitzler Syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
R-Pharm Overseas 505 Cost Boulevard South Suite #102 San Diego, California 92037 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-